Life Molecular Imaging – Website

Innovative PET imaging agents for earlier and improved diagnosis and better characterization of diseases

Search Icon

Search for:

Menu Toggle Icon

Skip to content

Home
About us
Molecular Imaging
- How It Works
- Value of Molecular Imaging
Research & Development
Products
News
- Current News
- Careers

Life Molecular Imaging Announces Presentation of New Clinical Data of the Next Generation Tau PET Tracer PI-2620 at the AD/PD 2019 Conference

27. March 201927. March 2019lifemolecular

Readmore: New clinical data of PI-2620 Tau-PET highlight the sensitive detection of Tau pathology in neurodegenerative diseases .

Life Molecular Imaging and XingImaging Announce PI-2620 Tau PET Tracer Production in Mainland China

26. October 201826. October 2018lifemolecular

Readmore: Life Molecular Imaging (LMI) and XingImaging announced that production of LMI’s 18F-labeled Tau PET imaging agent PI-2620 has commenced at XingImaging sites in China.

Life Molecular Imaging and SOFIE announce PI-2620 Tau PET Tracer Production in SOFIE Radiopharmacy Network

13. September 201813. September 2018lifemolecular

Readmore: PI-2620 Tau PET tracer production for clinical trial supply has commenced in SOFIE Radiopharmacy Network

Piramal Imaging becomes Life Molecular Imaging

27. August 201827. August 2018lifemolecular

Readmore: Following the recent acquisition by Alliance Medical Group, Piramal Imaging is being renamed Life Molecular Imaging

Alliance Medical completes the purchase of Piramal Imaging

26. June 201821. August 2018lifemolecular

Readmore: Alliance-Medical-completes-the-purchase-of-Piramal-Imaging

Posts navigation

Newer posts →

© Copyright 2018 Life Molecular Imaging

Data Protection & Cookies. Our site uses cookies.
Click here to learn more: Data protection

Imprint / Data protection